FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3840811 · Received May 30, 2014

Report

Report Number
1030489-2014-02668
Event Type
Injury
Date Received
May 30, 2014
Report Date
May 21, 2014
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT SUSTAINED UNSPECIFIED INJURIES FOLLOWING THE USE OF RHBMP-2/ACS IN AN UNSPECIFIED SPINAL FUSION SURGERY. NO ADDITIONAL INFORMATION WAS REPORTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2011: THE PATIENT PRESENTED WITH FOLLOWING PREOPERATIVE DIAGNOSES: L5/S1 SPONDYLOLISTHESIS WITH BILATERAL L5 PARS DEFECTS; L5/S1 LUMBAR STENOSIS; L4/5 DEGENERATIVE DISC DISEASE WITH HERNIATION; SPINAL INSTABILITY. THE PATIENT UNDERWENT THE FOLLOWING PROCEDURES: 1. BILATERALL5/S1 SEMIHEMILAMINECTOMY, MEDIAL FACETECTOMY AND PROXIMAL FORAMINOTOMY (GILL PROCEDURE) 2. BILATERAL L4/5 SEMIHEMILAMINECTOMY, MEDIAL FACETECTOMY AND PROXIMAL FORAMINOTOMY 3. L4/5 POSTERIOR LUMBAR INTERBODY FUSION WITH ACROMED INTERBODY DEVICE AND MASTERGRAFT 4. L4/L5/S1 POSTERIOR SEGMENTAL INSTRUMENTATION 5. L4/L5/S1 POSTERIOR/LATERAL ARTHRODESIS WITH LOCALLY HARVESTED BONE GRAFT, MASTERGRAFT AND INFUSE (BONE MORPHOGENIC PROTEIN) 6. MICROSURGICALLY ASSISTED DISSECTION 7. INTRAOPERATIVE INTERPRETATION OF RADIOGRAPHIC STUDIES 8. INTRATHECAL INJECTION OF DURAMORPH. PER OP NOTES, THE POSTEROLATERAL ELEMENTS WERE CAREFULLY DECORTICATED AND A COMBINATION OF LOCALLY HARVESTED MORSELIZED BONE GRAFT, MASTERGRAFT AND INFUSE WERE USED TO ACHIEVE ARTHRODESIS. A METICULOUS INTERNAL DISCECTOMY WAS PERFORMED. THE ENDPLATES WERE PREPARED BY SEQUENTIALLY INSERTING INTO THE DISC SPACE THE SHAVERS FOLLOWED BY THE PITUITARY RONGEURS AND CURETTES. THE ACROMED PEEK CAGE WAS PACKED WITH INFUSE (BONE MORPHOGENIC PROTEIN) AND WAS THEN INSERTED INTO THE L4/5 INTERSPACE, BEING COUNTERSUNK TO A DEPTH OF ~ 2 MILLIMETERS AND DIRECTED ACROSS THE MIDLINE IN "TLIF' FASHION. DISTRACTION WAS RELEASED AND GENTLE DISTRACTION APPLIED AT THE L4/5 LEVEL AND THE NERVE ROOTS WERE AGAIN INSPECTED. NO PATIENT COMPLICATIONS WERE REPORTED. (B)(6) 2011: INTRAOPERATIVE X-RAYS WERE PERFORMED AND INTERPRETED THROUGHOUT THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
318218 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 Other